课题基金 / 基金详情

THE ROLE OF ROSIGLITAZONE IN MODULATING HDL CHOLESTEROL IN SUBJECTS WITH TYPE

THE ROLE OF ROSIGLITAZONE IN MODULATING HDL CHOLESTEROL IN SUBJECTS WITH TYPE
罗格列酮在调节 HDL 胆固醇的作用
批准号:
7607475
负责人:
Annabelle Rodriguez
金额:
$0.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-09-16

项目摘要

项目成果

Annabelle Rodriguez的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is understand how rosiglitazone modulates HDL cholesterol levels.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THE ROLE OF THE HDL RECEPTOR, SCAVENGER RECEPTOR CLASS B TYPE I, IN HUMAN
  • 批准号:
    7607491
  • 项目类别:
  • 资助金额:
    $0.03万
  • 财政年份:
    2006
  • 负责人:
    Annabelle Rodriguez
  • 依托单位:
DEFICIENCY OF THE HDL RECEPTOR, SR-BI, IN HUMANS
  • 批准号:
    7607476
  • 项目类别:
  • 资助金额:
    $0.96万
  • 财政年份:
    2006
  • 负责人:
    Annabelle Rodriguez
  • 依托单位:
THE ROLE OF ROSIGLITAZONE IN MODULATING HDL CHOLESTEROL IN TYPE 2 DIABETES
  • 批准号:
    7375834
  • 项目类别:
  • 资助金额:
    $1.17万
  • 财政年份:
    2005
  • 负责人:
    Annabelle Rodriguez
  • 依托单位:
DEFICIENCY OF THE HDL RECEPTOR, SR-BI, IN HUMANS
  • 批准号:
    7375835
  • 项目类别:
  • 资助金额:
    $4.63万
  • 财政年份:
    2005
  • 负责人:
    Annabelle Rodriguez
  • 依托单位: